By Devika Patel
Knoxville, Tenn., April 7 - VentriPoint Diagnostics Ltd. said it settled a C$1.05 million private placement of debentures with a C$816,013 tranche. The deal priced for C$3 million on Dec. 8.
The debentures were sold in units of C$1.00 in 8% secured debentures and four share purchase warrants. Each warrant is exercisable at C$0.15 for three years.
The debentures may be redeemed after one year. They mature in two years.
Proceeds will be used to incur expenditures in preparation for and implementation of product and service commercialization and for working-capital purposes.
Based in Calgary, Alta., VentriPoint is a clinical diagnostic company.
| Issuer: | VentriPoint Diagnostics Ltd.
|
| Issue: | Units of C$1.00 in 8% secured debentures and four share purchase warrants
|
| Amount: | C$1,052,317
|
| Maturity: | Two years
|
| Coupon: | 8%
|
| Price: | Par
|
| Yield: | 8%
|
| Warrants: | Four warrants per unit
|
| Warrant expiration: | Three years
|
| Warrant strike price: | C$0.15
|
| Pricing date: | Dec. 8
|
| Settlement date: | April 7 (for C$816,013)
|
| Stock symbol: | TSX Venture: VPT
|
| Stock price: | C$0.11 at close Dec. 8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
